Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Traditionally, men have been more likely to be diagnosed with Parkinson disease. However, as people continue to live longer, cases of female patients with PD are becoming more…
Approximately one-third of patients with Huntington’s disease (HD) experience depression. In 21 published case reports where electroconvulsive therapy (ECT) was used to treat depression in patients with HD,…
A new study from the Radiological Society of North America reveals that changes in the visual system of patients diagnosed with Parkinson’s disease may provide important biomarkers for early detection…
Scientists at Northwestern University have discovered a link between Huntington’s Disease and dysfunction of the brain’s structure. These findings may explain the causes of the debilitating symptoms and…
Emily Ruether, MD, has built a career around the treatment of movement disorders. In this video, she discusses her approach to helping patients with certain conditions resume the…
